Nu Skin Enterprises (NYSE:NUS) Releases Q2 2026 Earnings Guidance

Nu Skin Enterprises (NYSE:NUS) issued an update on its second quarter 2026 earnings guidance on Thursday morning. The company provided earnings per share guidance of 0.150-0.250 for the period, compared to the consensus earnings per share estimate of 0.230. The company issued revenue guidance of $330.0 million-$360.0 million, compared to the consensus revenue estimate of $361.0 million. Nu Skin Enterprises also updated its FY 2026 guidance to 0.700-1.100 EPS.

Nu Skin Enterprises Stock Down 4.0%

Shares of Nu Skin Enterprises stock opened at $7.05 on Friday. The company has a quick ratio of 1.40, a current ratio of 2.08 and a debt-to-equity ratio of 0.25. Nu Skin Enterprises has a 52-week low of $5.78 and a 52-week high of $14.62. The company has a market capitalization of $339.08 million, a P/E ratio of 2.20 and a beta of 1.03. The company has a 50 day moving average of $7.48 and a 200 day moving average of $9.21.

Nu Skin Enterprises (NYSE:NUS) last released its quarterly earnings data on Friday, May 8th. The company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.15 by ($0.01). The firm had revenue of $320.61 million for the quarter, compared to analysts’ expectations of $329.70 million. Nu Skin Enterprises had a return on equity of 8.14% and a net margin of 10.79%. As a group, research analysts forecast that Nu Skin Enterprises will post 1 EPS for the current fiscal year.

Nu Skin Enterprises Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 10th. Investors of record on Friday, May 29th will be paid a dividend of $0.06 per share. The ex-dividend date is Friday, May 29th. This represents a $0.24 annualized dividend and a yield of 3.4%. Nu Skin Enterprises’s payout ratio is presently 7.50%.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on NUS shares. Zacks Research upgraded shares of Nu Skin Enterprises from a “strong sell” rating to a “hold” rating in a research report on Monday, April 13th. Wall Street Zen lowered shares of Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research note on Saturday, February 14th. Finally, Weiss Ratings reissued a “hold (c)” rating on shares of Nu Skin Enterprises in a research report on Thursday, January 22nd. Two analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Nu Skin Enterprises presently has an average rating of “Hold”.

Key Stories Impacting Nu Skin Enterprises

Here are the key news stories impacting Nu Skin Enterprises this week:

• Positive Sentiment: Board declared a quarterly cash dividend of $0.06 per share (payable June 10; ex-dividend May 29), implying a roughly 3.4% yield which supports income-focused holders. Nu Skin Announces Quarterly Dividend
• Neutral Sentiment: Management reiterated full-year FY2026 EPS range of $0.70–$1.10 and revenue $1.4B–$1.5B — the EPS range brackets the consensus (~$1.00) but is wide, leaving ambiguity on execution vs. upside. FY2026 Guidance Details
• Negative Sentiment: Q1 results missed estimates: adjusted EPS $0.14 vs. $0.15 consensus and revenue $320.6M vs. $329.7M expected — the beat/miss on both metrics is modest but negative given prior-year profitability. Q1 Earnings and Revenues Lag Estimates
• Negative Sentiment: Q2 guidance was conservative: EPS $0.150–$0.250 (consensus ~$0.230) and revenue $330M–$360M (consensus ~$361M) — the midpoint implies lower growth vs. expectations and is a clear near-term headwind. Q2 Guidance Update
• Negative Sentiment: Operational trends show declines: Q1 revenue down ~12% YoY, customers down ~14%, paid affiliates down ~8% — these metrics suggest customer/affiliate weakness that could pressure organic growth. Q1 Results and Operational Metrics

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. Charles Schwab Investment Management Inc. boosted its stake in shares of Nu Skin Enterprises by 22.5% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,621,785 shares of the company’s stock worth $25,222,000 after buying an additional 481,231 shares during the period. AQR Capital Management LLC raised its stake in shares of Nu Skin Enterprises by 59.2% during the fourth quarter. AQR Capital Management LLC now owns 799,120 shares of the company’s stock worth $7,688,000 after purchasing an additional 297,071 shares during the last quarter. Millennium Management LLC lifted its holdings in shares of Nu Skin Enterprises by 1,167.2% during the fourth quarter. Millennium Management LLC now owns 275,100 shares of the company’s stock worth $2,646,000 after purchasing an additional 253,390 shares during the period. Dimensional Fund Advisors LP grew its position in Nu Skin Enterprises by 16.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,373,372 shares of the company’s stock valued at $13,212,000 after buying an additional 193,987 shares during the last quarter. Finally, Bridgeway Capital Management LLC grew its position in Nu Skin Enterprises by 84.4% in the 3rd quarter. Bridgeway Capital Management LLC now owns 396,725 shares of the company’s stock valued at $4,836,000 after buying an additional 181,601 shares during the last quarter. 82.84% of the stock is currently owned by institutional investors and hedge funds.

About Nu Skin Enterprises

Nu Skin Enterprises, Inc is a Utah-based direct selling company that develops and distributes personal care products and dietary supplements. Operating through a network marketing model, Nu Skin offers a portfolio of wellness, anti-aging skin care, hair care and nutritional products designed to support healthy living and appearance. The company leverages independent distributors to market its offerings directly to consumers across multiple channels, including online platforms and localized events.

Founded in 1984 by Blake M.